Evidence map›Paper›PMID 26614223›Full record

ArticleHead & neck2016

Pretreatment serum xanthophyll concentrations as predictors of head and neck cancer recurrence and survival.

Anna E Arthur, Emily L Bellile, Laura S Rozek, Karen E Peterson, Jianwei Ren, Ethan Harris, Christie Mueller, Shruti Jolly, Lisa A Peterson, Gregory T Wolf and 1 more

Open access · greenAbstract read
In one paragraph

Article in Head & neck, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Pretreatment Dietary Patterns Are Associated with the Presence of Nutrition Impact Symptoms 1 Year after Diagnosis in Patients with Head and Neck Cancer.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2019
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Anna E ArthurDepartment of Nutrition Sciences, University of Alabama-Birmingham, Birmingham, Alabama.
Emily L BellileDepartment of Biostatistics, University of Michigan, Ann Arbor, Michigan.
Laura S RozekDepartment of Environmental Health Sciences, University of Michigan, Ann Arbor, Michigan.
Karen E PetersonDepartment of Environmental Health Sciences, University of Michigan, Ann Arbor, Michigan.
Jianwei RenDepartment of Family Medicine, University of Michigan, Ann Arbor, Michigan.
Ethan HarrisDepartment of Family Medicine, University of Michigan, Ann Arbor, Michigan.
Christie MuellerDepartment of Family Medicine, University of Michigan, Ann Arbor, Michigan.
Shruti JollyDepartment of Radiation Oncology, University of Michigan, Ann Arbor, Michigan.
Lisa A PetersonDepartment of Otolaryngology, University of Michigan, Ann Arbor, Michigan.
Gregory T WolfDepartment of Otolaryngology, University of Michigan, Ann Arbor, Michigan.
Zora DjuricDepartment of Environmental Health Sciences, University of Michigan, Ann Arbor, Michigan.
University of Michigan–Ann Arbor · USHarvard University · USMichigan Center for Translational Pathology · USUniversity of Alabama at Birmingham · US

Funding

XenograftP30CA046592 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI THEODORE S LAWRENCE · 1988 to 2026
$178.2M
Michigan Institute for Clinical and Health Research (MCHR)UL1TR000433 · NCATS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MASHOUR, GEORGE ALEXANDER · 2012 to 2016
$49.9M
Therapeutic Potential and Mechanism of Action of Potent Small Molecule InhibitorsP50CA097248 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI WOLF, GREGORY T · 2002 to 2013
$25.3M
Regional Pilot And Feasibility Study Grants ProgramP30DK020572 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Mehboob A Hussain · 2013 to 2026
$24.3M
Cancer Prevention & Control Training ProgramR25CA047888 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI DEMARK-WAHNEFRIED, WENDY, MENESES, KAREN M · 1988 to 2016
$11.2M
Training Program in Tumor MicroenvironmentT32CA009676 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Maria G Castro, Analisa Virginia DiFeo · 1992 to 2026
$7.3M
NCATS NIH HHS UL1 TR000433NCI NIH HHS P30 CA046592NCI NIH HHS P50 CA097248NCI NIH HHS R25 CA047888NCI NIH HHS T32 CA009676NIDDK NIH HHS P30 DK020572
6 · The paper itself

Abstract

backgroundThe purpose of this study was to examine associations of pretreatment serum carotenoids, tocopherols, and quercetin with prognosis in 154 patients newly diagnosed with head and neck cancer.

methodsPretreatment blood and health surveys were collected. Serum micronutrients were measured by high performance liquid chromatography. Data on recurrence and death were collected annually. Cox proportional hazards models measured associations of serum nutrient concentrations with recurrence and overall survival.

resultsDuring a median follow-up time of 37 months, there were 32 recurrences and 27 deaths. After controlling for covariates, subjects with high versus low serum xanthophyll and total carotenoid concentrations had significantly longer recurrence-free time (p = .002 and p = .02, respectively). Overall survival time was significantly longer in patients with high versus low serum xanthophyll concentrations (p = .02).

conclusionFuture research should evaluate the possible benefits of interventions to increase intakes of rich food sources of xanthophylls in this patient population. © 2015 Wiley Periodicals, Inc. Head Neck 38: E1591-E1597, 2016.

Indexed as

AdultAgedAged, 80 and overCarotenoidsFemaleHead and Neck NeoplasmsHumansMaleMiddle AgedNeoplasm Recurrence, LocalProspective StudiesQuercetinSurvival RateTocopherolsXanthophyllsCarotenoidsQuercetinTocopherolsXanthophyllshead and neck cancerquercetinrecurrenceserum micronutrientssurvivalxanthophylls

Identifiers

PMID26614223
PMCPMC4844799
OpenAlexW2172392628

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.